Job Description
Role and Responsibility
- Responsible for delivering and managing successful SAP Roll Outs for Accord Entities MM/EWM Module
- Design, Implement and Deploy SAP / Technical Solutions to achieve business goals
- Coordinate and communicate with business / Support Partner (Sajen) team to ensure that all incidents are resolved well in time (as per agreed SLA) and all Change Requests are delivered as per agreed timelines
- Support and Guidance to Support Partner (Sarjen) team wherever required so that business is not interrupted
- Training to Support Partner (Sarjen) team wherever required for desired skills
- Ensure IT controls, SOD conflicts
- Periodic Review of issues, communication with business, escalation to Management for any support
Qualification B tech / M tech / MBA
Experience 4+ Years (minimal 2 years Logistics Full Life Cycle Experience including Global and European implementation/Rollouts)
Skills:
- Preference - Pharma Companies working Experience or SAP Warehouse management as user for few years and IT SAP experience for 3+ Years, preferred to have SAP Certification in MM/EWM Module
- Module SAP MM/EWM Expert, Configuration and Integration Experience, Strong Cross functional knowledge (SAP ECC is Must, HANA Preferred)
- Exposure of handling RICEFs in MM/EWM areas
- Exposure of Cross Company Code Processes, Design & Solution Setup
- Technical Skills other than SAP functional knowledge mentioned above, he should have strong knowledge of:
- System Integration: Integration within SAP Landscape or Integration with non-SAP System
- Master Data Management
- GxP Knowledge
More Info
About Company
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business.
Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK.
Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests 6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products.
Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.
The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab.
Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.